Stockreport

CEL-SCI to Present New Data for Multikine® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 Congress

Cel-Sci Corporation  (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
PDF Data to be presented on Saturday, September 14 and published via a press release before the open of market on Monday, September 16 VIENNA, Va.--(BUSINESS WIRE)--CEL-S [Read more]